Crossmark

Is peptide receptor radionuclide therapy still a promising option for medullary thyroid carcinoma?

Published Online: 2024-11-29

Authors

de Andrade, Fernanda Accioly

Bulzico, Daniel

Corbo, Rossana

Vaisman, Fernanda
License Information

Text and Data Mining valid from 2024-11-29

Version of Record valid from 2024-11-29
More Information

Article History

Received: 5 October 2024

Accepted: 13 November 2024

First Online: 29 November 2024

Compliance with ethical standards

:

: The authors declare no competing interests.

Document is current